Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Conexeu Sciences Inc (CNXU)

Conexeu Sciences Inc (CNXU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
A $190 Billion Weight-Loss Boom Has Exposed a Tissue-Restoration Gap Today’s Injectables Were Not Built to Fill GlobeNewswire - Tue Jul 7, 8:00AM CDT

Study Highlights P.R.O.O.F study complete, marking an important catalyst. Conexeu has completed its P.R.O.O.F (Performance and Regeneration Outcomes of Flowable Collagen) preclinical program, which...

CNXU : 10.20 (+2.93%)
Conexeu Sciences Opens Vancouver R&D Facility to Advance Regenerative Tissue Platform GlobeNewswire - Thu Jun 25, 7:30AM CDT

RENO, Nev., June 25, 2026 (GLOBE NEWSWIRE) -- Conexeu Sciences Inc. (Nasdaq: CNXU) (“ Conexeu” or the “Company”), a biotechnology company advancing tissue regeneration, announced the opening...

CNXU : 10.20 (+2.93%)
Conexeu Expands Board, Executive, and Advisory Leadership With Five Appointments Post Nasdaq Listing GlobeNewswire - Mon Jun 15, 7:30AM CDT

RENO, Nev., June 15, 2026 (GLOBE NEWSWIRE) -- Conexeu Sciences Inc. (Nasdaq: CNXU) (“Conexeu” or the “Company”), a biotechnology company advancing tissue regeneration, today announced additions...

CNXU : 10.20 (+2.93%)
Conexeu Sciences Reports Manufacturing Scale Up and Regulatory Progress for Lead CXU™ Wound Care Program GlobeNewswire - Mon Jun 8, 7:30AM CDT

RENO, Nev., June 08, 2026 (GLOBE NEWSWIRE) -- Conexeu Sciences Inc. (Nasdaq: CNXU) (“Conexeu” or the “Company”) today announced progress in manufacturing scale up and standardized formulation...

CNXU : 10.20 (+2.93%)
MarketBeat.com
Before the IPO: 4 Companies That Rewarded Investors Who Got In Early MarketBeat - Thu Jun 4, 9:50AM CDT

Weiss Ratings analyst Chris Graebe outlines how Regulation A offerings let retail investors access private companies like FJET, NUCL, and CNXU before their public listings.

BUD : 79.61 (+0.34%)
FJET : 4.45 (-0.45%)
SPCX : 145.30 (-4.51%)
NUCL : 6.80 (-3.68%)
CNXU : 10.20 (+2.93%)
Conexeu Sciences to Ring Nasdaq Bell on June 10, 2026 GlobeNewswire - Wed Jun 3, 7:30AM CDT

RENO, Nev., June 03, 2026 (GLOBE NEWSWIRE) -- Conexeu Sciences Inc.   (Nasdaq: CNXU) ("Conexeu" or the "Company") , a biotechnology company advancing tissue regeneration, will ring the Nasdaq Closing...

CNXU : 10.20 (+2.93%)
UPDATE - Conexeu Sciences Initiates Preclinical Development Program for B.R.E.A.S.T.™ Bioregenerative Matrix Platform with Wake Forest Institute for Regenerative Medicine GlobeNewswire - Wed May 27, 9:36AM CDT

RENO, Nev., May 27, 2026 (GLOBE NEWSWIRE) -- Conexeu Sciences Inc.   (Nasdaq: CNXU) ("Conexeu" or the "Company") , a biotechnology company advancing tissue regeneration, today announced the launch...

CNXU : 10.20 (+2.93%)
Conexeu Sciences Commences Trading on Nasdaq Under Ticker Symbol "CNXU" Newsfile - Thu May 21, 11:18AM CDT

Public listing marks key milestone as Conexeu advances proprietary CXU(TM) platform and vision for regenerative medicine focused on biological restorationReno, Nevada--(Newsfile Corp. - May 21, 2026) -...

CNXU : 10.20 (+2.93%)

Barchart Exclusives

Broadcom Lands $30 Billion Chip Deal With Apple. Why It’s a Win-Win for AAPL and AVGO. Barchart - 1 hour ago
Broadcom strengthened its growth outlook by securing a $30 billion chip agreement with Apple through 2031. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.